Recruiting
Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
NCT06528769
- Conditions
- Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States